HLS Therapeutics Statistics

Total Valuation

TSX:HLS has a market cap or net worth of CAD 159.75 million. The enterprise value is 225.88 million.

Market Cap	159.75M
Enterprise Value	225.88M

Important Dates

The last earnings date was Thursday, May 8, 2025.

Earnings Date	May 8, 2025
Ex-Dividend Date	n/a

Share Statistics

TSX:HLS has 31.63 million shares outstanding. The number of shares has decreased by -1.10% in one year.

Current Share Class	31.63M
Shares Outstanding	31.63M
Shares Change (YoY)	-1.10%
Shares Change (QoQ)	+5.17%
Owned by Insiders (%)	0.68%
Owned by Institutions (%)	10.63%
Float	19.09M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.96
PB Ratio	1.66
P/TBV Ratio	n/a
P/FCF Ratio	10.35
P/OCF Ratio	10.32
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.98, with an EV/FCF ratio of 14.64.

EV / Earnings	-8.74
EV / Sales	2.77
EV / EBITDA	9.98
EV / EBIT	n/a
EV / FCF	14.64

Financial Position

The company has a current ratio of 1.43, with a Debt / Equity ratio of 0.95.

Current Ratio	1.43
Quick Ratio	1.07
Debt / Equity	0.95
Debt / EBITDA	4.05
Debt / FCF	5.94
Interest Coverage	-0.68

Financial Efficiency

Return on equity (ROE) is -23.08% and return on invested capital (ROIC) is -2.63%.

Return on Equity (ROE)	-23.08%
Return on Assets (ROA)	-2.28%
Return on Invested Capital (ROIC)	-2.63%
Return on Capital Employed (ROCE)	-4.93%
Revenue Per Employee	886,923
Profits Per Employee	-280,986
Employee Count	92
Asset Turnover	0.32
Inventory Turnover	1.76

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +35.75% in the last 52 weeks. The beta is 1.02, so TSX:HLS's price volatility has been similar to the market average.

Beta (5Y)	1.02
52-Week Price Change	+35.75%
50-Day Moving Average	4.49
200-Day Moving Average	3.91
Relative Strength Index (RSI)	65.53
Average Volume (20 Days)	6,789

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TSX:HLS had revenue of CAD 81.60 million and -25.85 million in losses. Loss per share was -0.82.

Revenue	81.60M
Gross Profit	59.38M
Operating Income	-9.21M
Pretax Income	-19.99M
Net Income	-25.85M
EBITDA	22.57M
EBIT	-9.21M
Loss Per Share	-0.82

Full Income Statement

Balance Sheet

The company has 25.49 million in cash and 91.62 million in debt, giving a net cash position of -66.13 million or -2.09 per share.

Cash & Cash Equivalents	25.49M
Total Debt	91.62M
Net Cash	-66.13M
Net Cash Per Share	-2.09
Equity (Book Value)	96.01M
Book Value Per Share	3.03
Working Capital	14.70M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 15.48 million and capital expenditures -48,870, giving a free cash flow of 15.43 million.

Operating Cash Flow	15.48M
Capital Expenditures	-48,870
Free Cash Flow	15.43M
FCF Per Share	0.49

Full Cash Flow Statement

Margins

Gross margin is 72.78%, with operating and profit margins of -11.29% and -31.68%.

Gross Margin	72.78%
Operating Margin	-11.29%
Pretax Margin	-24.50%
Profit Margin	-31.68%
EBITDA Margin	27.66%
EBIT Margin	-11.29%
FCF Margin	18.91%

Dividends & Yields

TSX:HLS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	1.10%
Shareholder Yield	n/a
Earnings Yield	-16.18%
FCF Yield	9.66%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

TSX:HLS has an Altman Z-Score of -0.9. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.9
Piotroski F-Score	n/a